LAWRENCE, Mass. – NxStage Medical, a medical technology company, has achieved a milestone of more than 5,000 patients having received a kidney transplant after performing more frequent home hemodialysis with its NxStage System One system. “It’s an incredibly rewarding moment for NxStage to celebrate with over 5,000 of our former patients and know that for many of them, more frequent home therapy with NxStage helped in their journey to transplantation,” said Jeff Burbank, Founder and CEO of NxStage Medical, in a statement. “It is moments like this that remind us of the impact we are making on patients’ lives.” Burbank said that patients on more frequent home hemodialysis with the NxStage System One have a 14% higher incidence of receiving a kidney transplant, and that more frequent home hemodialysis is also associated with: 13% lower risk of death compared to traditional in-center hemodialysis; 11% reduction in left ventricular hypertrophy; and an 87% improvement in recovery time after treatment.
You are here: / / NxStage Medical sees 5,000 patients with kidney transplants after home treatment